Percutaneous absorption composition
AssigneeMedrx Co., Ltd.
InventorsYasushi Miwa, Hidetoshi Hamamoto, Naoya Akazawa
Life of this patent
Estimating the term…
Abstract
The embodiments provide a percutaneous absorption composition for a basic medicament having improved transdermal absorbability. The percutaneous absorption composition comprises a sorbic acid and/or a metal sorbate as a percutaneous absorption promotor. The molar ration of the sorbic acid and/or the metal sorbate to the basic medicament is 0.5-2.5. The composition of the present disclosure may further comprise a basic component.
Claims14
A percutaneous absorption non-aqueous composition comprising a basic medicament or a salt thereof and a sorbate component, wherein the molar ratio of the sorbate component to the basic medicament or a salt thereof is 0.5-2.5, and the sorbate component comprises a metal sorbate selected from the group consisting of sodium sorbate, potassium sorbate, and calcium sorbate.
Dependencies are inferred from the claim text.